ARE Alexandria Real Estate Equities, Inc. Common Stock
NYSE · Real Estate · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 3, 2026ARE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ARE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Alexandria Real Estate Equities, Inc. Common Stock Company overview from Wikipedia
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square (Cambridge, Massachusetts) in the Boston area.
The company is dependent on the life sciences industry and funding for research by the United States Government.
The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms.
The company is named after Alexandria, Egypt because of that city's connection to science.
Investments
As of December 31, 2024, the company owned or had investments in 391 properties containing 44.1 million square feet.
The company's largest tenants are as follows:
The company's revenues are derived in the following markets:
History
In 1993, one of the partners of Jacobs Engineering Group, Jerry M. Sudarsky, was presented with a Business Plan written by Kendell R. Lang titled BioProperties Management Group, Inc., which was a plan to form a REIT dedicated to funding biotech properties. The initial business plan included founders Kendell Lang, Alan Gold, Gary Kreitzer, and Steven Stone as part of the initial management team. Jacobs approached Joel S. Marcus, a lawyer and CPA, with the idea of representing their interests in this company to oversee the management team who intended to provide laboratories and office space to biotech firms. Jacobs invested in the company with $5 million.
Its first purchase was of 4 buildings in San Diego which had been negotiated and structured by Kendell R. Lang.
In 1997, it became a public company via an initial public offering, raising $155 million.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ARE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -7.85Y avg ≈77.5 | ≈77.5 | · | · | |
| P/S (TTM) | 2.85Y avg ≈8.4 | ≈8.4 | 5.9 | Undervalued | |
| P/B (MRQ) | 0.55Y avg ≈1.2 | ≈1.2 | 2.0 | Undervalued | |
| Price / Cash Flow | 5.75Y avg ≈16.9 | ≈16.9 | 14.3 | Undervalued | |
| Price / Tangible Book | 0.55Y avg ≈1.2 | ≈1.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ARE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Net Profit Margin (TTM) | -36.1%5Y avg ≈2.8% | ≈2.8% | 5.7% | Weak | |
| ROA (TTM) | -2.8%5Y avg ≈0.18% | ≈0.18% | 1.5% | Weak | |
| ROE (TTM) | -6.3%5Y avg ≈0.16% | ≈0.16% | 2.5% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ARE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -2.9%5Y avg ≈10.2% | ≈10.2% | · | · | |
| Revenue CAGR 3Y | 5.3%5Y avg ≈11.5% | ≈11.5% | · | · | |
| Revenue CAGR 5Y | 9.9% | · | · | · | |
| EPS YoY | 233.3%5Y avg ≈24.3% | ≈24.3% | · | · | |
| Net Income YoY | 211.6%5Y avg ≈24.2% | ≈24.2% | · | · | |
| EPS CAGR 3Y | -22.2% | · | · | · | |
| Net Income CAGR 3Y | -17.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ARE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.1 | ≈0.1 | 0.1 | Weak | |
| Revenue / Employee | ≈$5.9M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 30, 2026 | $0.72 | USD | ≈6.1% |
| Jun 30, 2026 | $0.72 | USD | ≈6.6% |
| Mar 31, 2026 | $0.72 | USD | ≈8.8% |
| Dec 31, 2025 | $0.72 | USD | ≈9.6% |
| Sep 30, 2025 | $1.32 | USD | ≈6.3% |
| Jun 30, 2025 | $1.32 | USD | ≈7.2% |
| Mar 31, 2025 | $1.32 | USD | ≈5.7% |
| Dec 31, 2024 | $1.32 | USD | ≈5.3% |
| Sep 30, 2024 | $1.30 | USD | ≈4.3% |
| Jun 28, 2024 | $1.30 | USD | ≈4.3% |
| Mar 27, 2024 | $1.27 | USD | ≈3.9% |
| Dec 28, 2023 | $1.27 | USD | ≈3.8% |
| Sep 28, 2023 | $1.24 | USD | ≈4.9% |
| Jun 29, 2023 | $1.24 | USD | ≈4.3% |
| Mar 30, 2023 | $1.21 | USD | ≈3.9% |
| Dec 29, 2022 | $1.21 | USD | ≈3.3% |
| Sep 29, 2022 | $1.18 | USD | ≈3.4% |
| Jun 29, 2022 | $1.18 | USD | ≈3.2% |
| Mar 30, 2022 | $1.15 | USD | ≈2.2% |
| Dec 30, 2021 | $1.15 | USD | ≈2.0% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $-0.43 | $0.87 | -149.3% |
| March 31, 2026 | $2.10 | $0.13 | 1459.0% | |
| Dec. 31, 2025 | $-6.35 | $0.28 | -2332.0% | |
| Sept. 30, 2025 | $-1.38 | $0.50 | -374.4% | |
| June 30, 2025 | $-0.64 | $0.61 | -205.6% | |
| March 31, 2025 | $-0.07 | $0.68 | -110.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.03B | $3.12B | $2.89B | $2.59B | $2.11B | $1.89B | $1.53B | $1.33B | $1.13B | $922M | |
| SG&A Expense | $117M | $168M | $199M | $177M | $151M | $133M | $109M | $90M | $75M | $64M | |
| Operating Expenses | $4.82B | $2.69B | $2.69B | $2.13B | $1.86B | $1.64B | $1.33B | $1.11B | $950M | $975M | |
| Interest Expense | $227M | $186M | $74M | $94M | $142M | $172M | $174M | $157M | $129M | $107M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $7M | |
| Net Income | $-1.43B | $323M | $104M | $522M | $571M | $771M | $363M | $379M | $169M | $-66M | |
| EPS (Basic) | $-8.44 | $1.80 | $0.54 | $3.18 | $3.83 | $6.03 | $3.13 | $3.53 | $1.59 | $-1.99 | |
| EPS (Diluted) | $-8.44 | $1.80 | $0.54 | $3.18 | $3.82 | $6.01 | $3.12 | $3.52 | $1.58 | $-1.99 | |
| Shares (Basic) | 170,307,000 | 172,071,000 | 170,909,000 | 161,659,000 | 146,921,000 | 126,106,000 | 112,204,000 | 103,010,000 | 91,546,000 | 76,103,000 | |
| Shares (Diluted) | 170,307,000 | 172,071,000 | 170,909,000 | 161,659,000 | 147,460,000 | 126,490,000 | 112,524,000 | 103,321,000 | 92,063,000 | 76,103,000 |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $549M | $552M | $618M | $825M | $361M | $569M | $190M | $234M | $254M | $125M | |
| PP&E (Net) | $70M | $40M | $27M | $23M | $26M | $31M | $23M | $15M | $11M | $13M | |
| Total Assets | $34.08B | $37.53B | $36.77B | $35.52B | $30.22B | $22.83B | $18.39B | $14.46B | $12.10B | $10.35B | |
| Total Liabilities | $14.93B | $15.13B | $14.15B | $12.84B | $11.19B | $9.38B | $8.22B | $6.57B | $5.62B | $4.97B | |
| Long-term Debt | $12.40B | $12.24B | $11.32B | $10.16B | $8.79B | $7.56B | $6.78B | $5.48B | $4.76B | $4.16B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $998.0K | $877.0K | |
| Paid-in Capital | $15.50B | $17.93B | $18.49B | $18.99B | $16.20B | $11.73B | $8.87B | $7.29B | $5.82B | $4.67B | |
| AOCI | $-29M | $-46M | $-16M | $-21M | $-7M | $-7M | $-10M | $-10M | $50M | $5M | |
| Stockholders' Equity | $15.47B | $17.89B | $18.47B | $18.97B | $16.19B | $11.73B | $8.87B | $7.34B | $5.95B | $4.90B | |
| Liabilities + Equity | $34.08B | $37.53B | $36.77B | $35.52B | $30.22B | $22.83B | $18.39B | $14.46B | $12.10B | $10.35B | |
| Shares Outstanding | 170,537,867 | 172,203,443 | 171,910,599 | 170,748,395 | 158,043,880 | 136,690,329 | 120,800,315 | 111,011,816 | 99,783,686 | 87,665,880 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.35B | $1.20B | $1.09B | $1.00B | $821M | $698M | $545M | $478M | $417M | $313M | |
| Stock-based Comp | $41M | $60M | $83M | $58M | $49M | $44M | $44M | $35M | $26M | $25M | |
| Operating Cash Flow | $1.41B | $1.50B | $1.63B | $1.29B | $1.01B | $883M | $684M | $570M | $451M | $393M | |
| Investing Cash Flow | $362M | $-1.51B | $-2.50B | $-5.08B | $-7.11B | $-3.28B | $-3.64B | $-2.16B | $-1.74B | $-1.50B | |
| Stock Issued | $0 | $27M | $104M | $2.35B | $3.53B | $2.32B | $1.22B | $1.29B | $1.28B | $1.43B | |
| Stock Repurchased | $208M | $50M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-208M | $-23M | $104M | $2.35B | $3.50B | $2.32B | $1.22B | $1.29B | $1.28B | $1.43B | |
| Dividends Paid | · | $899M | $848M | $758M | $656M | $533M | $451M | $386M | $322M | $263M | |
| Financing Cash Flow | $-1.78B | $-93M | $674M | $4.23B | $5.92B | $2.75B | $2.93B | $1.59B | $1.42B | $1.09B | |
| Net Change in Cash | $-6M | $-101M | $-197M | $443M | $-182M | $355M | $-29M | $-5M | $136M | $-13M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -47.2% | 10.4% | 3.6% | 20.2% | 27.0% | 40.9% | 23.7% | 28.6% | · | · | |
| ROA | -4.0% | 0.87% | 0.29% | 1.6% | 2.1% | 3.7% | 2.2% | 2.9% | 1.5% | -0.69% | |
| ROE | -8.6% | 1.8% | 0.55% | 3.0% | 4.1% | 7.5% | 4.5% | 5.7% | 3.1% | -1.5% |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $90.71 | $103.88 | $107.45 | $111.11 | $102.44 | $85.78 | $73.39 | $66.14 | $59.63 | $55.85 | |
| Revenue / Share | $17.77 | $18.11 | $16.88 | $16.02 | $14.34 | $14.91 | $13.61 | $12.85 | · | · | |
| Cash Flow / Share | $8.30 | $8.74 | $9.54 | $8.01 | $6.85 | $6.98 | $6.08 | $5.52 | $4.89 | · | |
| Cash / Share | $3.22 | $3.21 | $3.60 | $4.83 | $2.29 | $4.16 | $1.57 | $2.11 | $2.55 | $1.43 | |
| Dividend / Share | $4.68 | $5.19 | $4.96 | $4.72 | $4.48 | $4.24 | $4.00 | $3.73 | $3.45 | $3.23 | |
| EPS (TTM) | $-8.44 | $1.80 | $0.54 | $3.18 | $3.82 | $6.01 | $3.12 | $3.52 | $1.58 | $-1.99 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.9% | 8.0% | 11.5% | 22.5% | 12.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 13.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.9% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 233.3% | -83.0% | -16.8% | -36.4% | · | · | · | · | · | |
| EPS CAGR 3Y | · | -22.2% | -55.2% | · | · | · | · | · | · | · | |
| Net Income YoY | · | 211.6% | -80.1% | -8.7% | -25.9% | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -17.3% | -48.8% | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.03B | $3.12B | $2.89B | $2.59B | $2.11B | $1.89B | $1.53B | $1.33B | $1.13B | $922M | |
| Net Income TTM | $-1.43B | $323M | $104M | $522M | $571M | $771M | $363M | $379M | $169M | $-66M | |
| Market Cap | $8.35B | $16.80B | $21.79B | $24.87B | $35.24B | $24.36B | $19.52B | $12.79B | $13.03B | $9.74B | |
| P/E | -5.8 | 54.2 | 234.8 | 45.8 | 58.4 | 29.7 | 51.8 | 32.7 | 82.7 | -55.8 | |
| P/S | 2.8 | 5.4 | 7.6 | 9.6 | 16.7 | 12.9 | 12.7 | 9.6 | 11.6 | 10.6 | |
| P/B | 0.5 | 0.9 | 1.2 | 1.3 | 2.2 | 2.1 | 2.2 | 1.7 | 2.2 | 2.0 | |
| P / Tangible Book | 0.5 | 0.9 | 1.2 | 1.3 | 2.2 | 2.1 | · | · | · | · | |
| P / Cash Flow | 5.9 | 11.2 | 13.4 | 19.2 | 34.9 | 27.6 | 28.5 | 22.4 | 28.9 | 24.8 | |
| Dividend Yield | · | 5.3% | 3.9% | 3.0% | 1.9% | 2.2% | 2.3% | 3.0% | 2.5% | 2.7% | |
| Earnings Yield | -17.2% | 1.8% | 0.43% | 2.2% | 1.7% | 3.4% | 1.9% | 3.0% | 1.2% | -1.8% | |
| Annual Payout | · | $899M | $848M | $758M | $656M | $533M | $451M | $386M | $322M | $263M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $663M | $671M | $754M | $752M | $762M | $758M | $789M | $792M | $767M | $769M | $757M | $714M | $714M | $701M | $670M | $660M | |
| SG&A Expense | $37M | $35M | $28M | $29M | $29M | $31M | $33M | $44M | $45M | $47M | $59M | $46M | $46M | $48M | $43M | $50M | |
| Operating Expenses | $835M | $634M | $2.37B | $988M | $785M | $682M | $845M | $620M | $629M | $594M | $871M | $565M | $717M | $534M | $556M | $568M | |
| Interest Expense | $64M | $65M | $66M | $55M | $55M | $51M | $56M | $44M | $46M | $41M | $32M | $11M | $17M | $14M | $18M | $23M | |
| Net Income | $-73M | $362M | $-1.08B | $-233M | $-107M | $-9M | $-62M | $168M | $47M | $171M | $-88M | $24M | $90M | $78M | $54M | $345M | |
| EPS (Basic) | $-0.43 | $2.10 | $-6.35 | $-1.38 | $-0.64 | $-0.07 | $-0.38 | $0.96 | $0.25 | $0.97 | $-0.54 | $0.13 | $0.51 | $0.44 | $0.36 | $2.11 | |
| EPS (Diluted) | $-0.43 | $2.10 | $-6.35 | $-1.38 | $-0.64 | $-0.07 | $-0.38 | $0.96 | $0.25 | $0.97 | $-0.54 | $0.13 | $0.51 | $0.44 | $0.36 | $2.11 | |
| Shares (Basic) | 170,718,000 | 170,598,000 | · | 170,181,000 | 170,135,000 | 170,522,000 | · | 172,058,000 | 172,013,000 | 171,949,000 | · | 170,890,000 | 170,864,000 | 170,784,000 | · | 161,554,000 | |
| Shares (Diluted) | 170,718,000 | 170,867,000 | · | 170,181,000 | 170,135,000 | 170,522,000 | · | 172,058,000 | 172,013,000 | 171,949,000 | · | 170,890,000 | 170,864,000 | 170,784,000 | · | 161,554,000 |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $470M | $419M | $549M | $579M | $521M | $476M | $552M | $563M | $561M | $722M | · | $532M | $924M | $1.26B | · | $534M | |
| PP&E (Net) | $76M | $80M | $70M | $63M | $54M | $47M | $40M | $36M | $33M | $28M | · | $26M | $24M | $23M | · | $23M | |
| Total Assets | $34.63B | $34.17B | $34.08B | $37.38B | $37.62B | $37.60B | $37.53B | $38.49B | $37.85B | $37.70B | · | $36.78B | $36.66B | $36.91B | · | $34.37B | |
| Total Liabilities | $15.46B | $14.80B | $14.93B | $16.26B | $15.88B | $15.60B | $15.13B | $15.78B | $15.18B | $14.94B | · | $14.07B | $13.89B | $14.23B | · | $13.11B | |
| Long-term Debt | $12.81B | $12.52B | $12.40B | $13.59B | $13.29B | $13.09B | · | $12.69B | $12.42B | $12.22B | · | $11.20B | $11.18B | $11.54B | · | $10.53B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Paid-in Capital | $15.59B | $15.76B | $15.50B | $16.67B | $17.20B | $17.51B | $17.93B | $18.24B | $18.28B | $18.43B | · | $18.65B | $18.81B | $18.90B | · | $17.64B | |
| AOCI | $-33M | $-31M | $-29M | $-32M | $-27M | $-46M | $-46M | $-23M | $-28M | $-24M | · | $-25M | $-17M | $-21M | · | $-25M | |
| Stockholders' Equity | $15.55B | $15.73B | $15.47B | $16.64B | $17.18B | $17.46B | $17.89B | $18.22B | $18.26B | $18.41B | · | $18.63B | $18.80B | $18.88B | · | $17.62B | |
| Liabilities + Equity | $34.63B | $34.17B | $34.08B | $37.38B | $37.62B | $37.60B | $37.53B | $38.49B | $37.85B | $37.70B | · | $36.78B | $36.66B | $36.91B | · | $34.37B | |
| Shares Outstanding | 170,728,916 | 170,712,290 | 170,537,867 | 170,339,080 | 170,146,069 | 170,129,883 | 172,203,443 | 172,244,401 | 172,017,674 | 172,007,967 | 171,910,599 | 170,996,839 | 170,869,778 | 170,859,704 | 170,748,395 | 162,619,535 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $304M | $305M | $322M | $340M | $346M | $342M | $330M | $294M | $291M | $288M | $285M | $269M | $274M | $265M | $264M | $255M | |
| Stock-based Comp | $10M | $11M | $8M | $10M | $13M | $10M | $12M | $16M | $15M | $17M | $35M | $16M | $15M | $16M | $12M | $18M | |
| Operating Cash Flow | $337M | $197M | $312M | $433M | $460M | $208M | $274M | $477M | $412M | $341M | $429M | $418M | $478M | $306M | $401M | $363M | |
| Investing Cash Flow | $-410M | $-585M | $1.80B | $-408M | $-375M | $-655M | $446M | $-488M | $-574M | $-895M | $-390M | $-676M | $-394M | $-1.04B | $-1.36B | $-624M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $104M | $0 | $0 | $0 | $1.50B | $199M | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $208M | $50M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-208M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $124M | $124M | · | $227M | $227M | $230M | $227M | $227M | $222M | $222M | $214M | $215M | $209M | $209M | $194M | $193M | |
| Financing Cash Flow | $125M | $258M | $-2.14B | $31M | $-41M | $371M | $-739M | $25M | $-4M | $624M | $55M | $-134M | $-422M | $1.17B | $951M | $610M | |
| Net Change in Cash | $52M | $-130M | $-30M | $56M | $44M | $-76M | $-20M | $14M | $-166M | $71M | $93M | $-393M | $-338M | $440M | $-8M | $349M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -11.0% | 53.9% | · | -30.9% | -14.0% | -1.2% | · | 21.2% | 6.1% | 22.2% | · | 3.4% | 12.6% | 11.1% | · | 52.2% | |
| ROA | -0.20% | 1.0% | · | -0.61% | -0.28% | -0.02% | · | 0.45% | 0.13% | 0.46% | · | 0.07% | 0.26% | 0.22% | · | 1.1% | |
| ROE | -0.44% | 2.2% | · | -1.3% | -0.60% | -0.05% | · | 0.91% | 0.25% | 0.91% | · | 0.13% | 0.50% | 0.43% | · | 2.1% |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $91.10 | $92.17 | · | $97.68 | $100.94 | $102.65 | · | $105.77 | $106.14 | $107.05 | · | $108.94 | $110.01 | $110.52 | · | $108.33 | |
| Revenue / Share | $3.88 | $3.93 | · | $4.42 | $4.48 | $4.45 | · | $4.60 | $4.46 | $4.47 | · | $4.18 | $4.18 | $4.10 | · | $4.08 | |
| Cash Flow / Share | · | $1.15 | · | · | · | $1.22 | · | · | · | $1.98 | · | · | · | $1.79 | · | · | |
| Cash / Share | $2.76 | $2.45 | · | $3.40 | $3.06 | $2.80 | · | $3.27 | $3.26 | $4.20 | · | $3.11 | $5.41 | $7.39 | · | $3.28 | |
| Dividend / Share | $0.72 | $0.72 | $0.72 | $1.32 | $1.32 | $1.32 | $1.32 | $1.30 | $1.30 | $1.27 | $1.27 | $1.24 | $1.24 | $1.21 | $1.21 | $1.18 | |
| EPS (TTM) | $-6.06 | $-6.27 | · | $-2.47 | $-0.13 | $0.76 | · | $1.64 | $0.81 | $1.07 | · | $1.44 | $3.42 | $4.58 | · | $3.32 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.84B | $2.94B | · | $3.06B | $3.10B | $3.11B | · | $3.08B | $3.01B | $2.95B | · | $2.80B | $2.74B | $2.67B | · | $2.50B | |
| Net Income TTM | $-1.02B | $-1.06B | · | $-411M | $-10M | $143M | · | $297M | $153M | $196M | · | $246M | $567M | $749M | · | $542M | |
| Market Cap | $9.02B | $7.92B | · | $14.20B | $12.36B | $15.74B | · | $20.45B | $20.12B | $22.17B | · | $17.12B | $19.39B | $21.46B | · | $22.80B | |
| P/E | -8.7 | -7.4 | · | -33.7 | -558.7 | 121.7 | · | 72.4 | 144.4 | 120.5 | · | 69.5 | 33.2 | 27.4 | · | 42.2 | |
| P/S | 3.2 | 2.7 | · | 4.6 | 4.0 | 5.1 | · | 6.6 | 6.7 | 7.5 | · | 6.1 | 7.1 | 8.0 | · | 9.1 | |
| P/B | 0.6 | 0.5 | · | 0.9 | 0.7 | 0.9 | · | 1.1 | 1.1 | 1.2 | · | 0.9 | 1.0 | 1.1 | · | 1.3 | |
| P / Tangible Book | 0.6 | 0.5 | · | 0.9 | 0.7 | 0.9 | · | 1.1 | 1.1 | 1.2 | · | 0.9 | 1.0 | 1.1 | · | 1.3 | |
| P / Cash Flow | · | 40.3 | · | · | · | 75.7 | · | · | · | 65.0 | · | · | · | 70.2 | · | · | |
| Dividend Yield | · | · | · | 6.4% | 7.4% | 5.8% | · | 4.3% | 4.3% | 3.9% | · | 4.8% | 4.2% | 3.6% | · | 3.2% | |
| Earnings Yield | -11.5% | -13.5% | · | -3.0% | -0.18% | 0.82% | · | 1.4% | 0.69% | 0.83% | · | 1.4% | 3.0% | 3.6% | · | 2.4% | |
| Payout Ratio | · | 34.2% | · | · | · | -2572.8% | · | · | · | 130.1% | · | · | · | 268.6% | · | · | |
| Annual Payout | · | · | · | $912M | $912M | $907M | · | $886M | $873M | $860M | · | $827M | $805M | $783M | · | $738M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $3.03B | $3.12B | $2.89B | $2.59B | $2.11B |
| Net Income | $-1.43B | $323M | $104M | $522M | $571M |
| Diluted EPS | $-8.44 | $1.80 | $0.54 | $3.18 | $3.82 |
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 661 filers · $10.2B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 112 (+13 vs prior Q) | 69 (-33 vs prior Q) | 232 (+21 vs prior Q) | 196 (-9 vs prior Q) | +26.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1,263,664,616 | 25,820,691 | 12.42% | Shares |
| BlackRock, Inc. | $1,146,423,207 | 21,692,019 | 11.27% | Shares |
| NORGES BANK | $868,730,490 | 16,437,663 | 8.54% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $739,972,352 | 14,001,369 | 7.27% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $573,021,633 | 10,842,415 | 5.63% | Shares |
| STATE STREET CORP | $567,535,631 | 10,596,116 | 5.58% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $404,198,856 | 7,648,039 | 3.97% | Shares |
| Invesco Ltd. | $374,193,973 | 7,080,302 | 3.68% | Shares |
| APG Asset Management US Inc. | $370,079,243 | 6,981,310 | 3.64% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $243,652,935 | 4,617,801 | 2.40% | Shares |
| MORGAN STANLEY | $155,847,784 | 2,948,869 | 1.53% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $151,223,405 | 2,861,370 | 1.49% | Shares |
| GOLDMAN SACHS GROUP INC | $142,895,474 | 2,703,793 | 1.40% | Shares |
| CENTERSQUARE INVESTMENT MANAGEMENT LLC | $124,385,436 | 2,353,556 | 1.22% | Shares |
| NORTHERN TRUST CORP | $123,308,457 | 2,333,178 | 1.21% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $109,350,296 | 2,068,746 | 1.07% | Shares |
| JPMORGAN CHASE & CO | $79,632,825 | 1,425,576 | 0.78% | Shares |
| Bank of New York Mellon Corp | $79,253,055 | 1,499,585 | 0.78% | Shares |
| Legal & General Group Plc | $76,646,661 | 1,450,268 | 0.75% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $73,816,758 | 1,396,722 | 0.73% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $70,528,325 | 1,334,500 | 0.69% | Put option |
| BNP PARIBAS FINANCIAL MARKETS | $68,010,868 | 1,286,866 | 0.67% | Shares |
| TOWN LANE MANAGEMENT LP | $66,062,500 | 1,250,000 | 0.65% | Shares |
| HSBC HOLDINGS PLC | $64,485,182 | 1,208,572 | 0.63% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $62,057,504 | 1,336,870 | 0.61% | Shares |
| BANK OF AMERICA CORP /DE/ | $61,516,126 | 1,163,976 | 0.60% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $56,968,918 | 1,077,936 | 0.56% | Shares |
| UBS Group AG | $51,291,370 | 970,508 | 0.50% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $48,267,905 | 913,300 | 0.47% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $47,342,132 | 895,783 | 0.47% | Shares |
| DEUTSCHE BANK AG\ | $46,358,276 | 877,167 | 0.46% | Shares |
| EARNEST PARTNERS LLC | $45,847,058 | 867,494 | 0.45% | Shares |
| STRS OHIO | $45,416,912 | 859,355 | 0.45% | Shares |
| MILLENNIUM MANAGEMENT LLC | $35,606,789 | 673,733 | 0.35% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $34,922,064 | 660,777 | 0.34% | Shares |
| BANK OF MONTREAL /CAN/ | $29,004,291 | 548,804 | 0.29% | Shares |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $28,822,593 | 545,366 | 0.28% | Shares |
| CITIGROUP INC | $28,746,383 | 543,924 | 0.28% | Shares |
| Balyasny Asset Management L.P. | $28,343,138 | 536,294 | 0.28% | Shares |
| Quantinno Capital Management LP | $28,206,610 | 533,710 | 0.28% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $26,496,348 | 501,350 | 0.26% | Shares |
| MACKENZIE FINANCIAL CORP | $24,854,457 | 470,283 | 0.24% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24,480,120 | 463,200 | 0.24% | Call option |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24,464,582 | 462,906 | 0.24% | Shares |
| Amundi | $24,139,095 | 456,633 | 0.24% | Shares |
| PRUDENTIAL FINANCIAL INC | $23,800,100 | 450,333 | 0.23% | Shares |
| Russell Investments Group, Ltd. | $23,729,470 | 448,996 | 0.23% | Shares |
| FMR LLC | $23,617,236 | 446,873 | 0.23% | Shares |
| AMERICAN CENTURY COMPANIES INC | $23,342,577 | 441,676 | 0.23% | Shares |
| DUFF & PHELPS INVESTMENT MANAGEMENT CO | $22,498,510 | 425,705 | 0.22% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Alexandria Real Estate Equities, Inc., Alexandria Venture Investments, LLC ×4 filings | April 1, 2024 | · | Initial filing | M&A / sale | SEC |
| Alexandria Real Estate Equities Inc., Alexandria Equities, LLC | May 27, 2016 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 48 insiders · 30 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Peter M Moglia | Chief Executive Officer | Sept. 30, 2026 F | 370,886 | 0 | 0 | $0 |
| Stephen Richardson | Co-Chief Executive Officer | July 31, 2022 F | 173,945 | 0 | 0 | $0 |
| Marc E Binda | CFO & Treasurer | June 9, 2026 S | 188,264 | 0 | 1 | $-108,000 |
| Dean A Shigenaga | Former President and CFO | Sept. 15, 2023 F | 172,479 | 0 | 0 | $0 |
| John Hart Cole | Co-President, & Co-RMD | Sept. 15, 2026 F | 106,731 | 0 | 0 | $0 |
| Hunter Kass | Co-President and RMD | Jan. 23, 2026 F | 236,887 | 0 | 0 | $0 |
| Daniel J Ryan | Co-President and RMD | Dec. 15, 2025 F | 217,609 | 0 | 0 | $0 |
| Thomas J Andrews | Co-President | Aug. 7, 2020 S | 114,994 | 0 | 0 | $0 |
| Joseph Hakman | Co-Chief Operating Officer | March 31, 2026 A | 99,160 | 0 | 0 | $0 |
| Lawrence J Diamond | Co-Chief Operating Officer | Jan. 23, 2026 F | 159,890 | 0 | 0 | $0 |
| Jennifer Banks | Co-Chief Operating Officer | April 30, 2020 S | 60,571 | 0 | 0 | $0 |
| Gregory Calvin Thomas | EVP - CTO | Sept. 15, 2026 F | 31,928 | 1 | 0 | $143,500 |
| Jesse J. Nelson | EVP - RMD | Sept. 15, 2026 F | 95,033 | 0 | 0 | $0 |
| Bret E. Gossett | EVP - Co-RMD | Sept. 15, 2026 F | 52,370 | 0 | 1 | $-251,792 |
| Hallie E. Kuhn | EVP - Cap Market & Co-Lead -LS | Sept. 15, 2026 F | 47,387 | 0 | 1 | $-25,835 |
| Jenna R. Foger | EVP - Co-Lead - Life Science | Sept. 15, 2026 F | 67,272 | 0 | 0 | $0 |
| Blake L. Stevens | Regional Market Director | Sept. 15, 2026 F | 29,064 | 0 | 0 | $0 |
| Michael E. Boss | Co-Regional Market Director | Sept. 15, 2026 F | 51,345 | 0 | 0 | $0 |
| Kristina Fukuzaki-Carlson | EVP - Business Operations | Sept. 11, 2026 S | 39,152 | 0 | 1 | $-849,073 |
| Joel S Marcus | Executive Chairman | Sept. 11, 2026 P | 597,724 | 10 | 0 | $2,905,862 |
| Andres Gavinet | Chief Accounting Officer | Aug. 31, 2026 S | 102,516 | 0 | 1 | $-509,300 |
| Joshua J. Mitchell | Regional Market Director | March 31, 2026 A | 25,049 | 0 | 0 | $0 |
| Orraparn C. Lee | EVP - Accounting | March 31, 2026 A | 68,768 | 0 | 0 | $0 |
| Madeleine Thorp Alsbrook | EVP - Talent Management | March 31, 2026 A | 38,781 | 0 | 1 | $-160,879 |
| Jackie B. Clem | General Counsel & Secretary | March 31, 2026 A | 73,044 | 0 | 0 | $0 |
| Gary D. Dean | EVP, Real Estate Legal Affairs | March 31, 2026 A | 68,314 | 0 | 0 | $0 |
| Vincent Ciruzzi | Chief Development Officer | Dec. 31, 2024 F | 72,820 | 0 | 0 | $0 |
| John H Cunningham | EVP - Regional Market Director | Dec. 15, 2023 A | 79,283 | 0 | 0 | $0 |
| Terezia C Nemeth | EVP - Regional Market Director | Dec. 15, 2022 F | 28,793 | 0 | 0 | $0 |
| Peter Nelson | Corporate Secretary | April 1, 2005 A | 109,974 | 0 | 0 | $0 |
| Michael A Woronoff | Director | Sept. 30, 2026 A | 29,401 | 0 | 0 | $0 |
| Sheila K. Mcgrath | Director | July 15, 2026 A | 12,205 | 1 | 0 | $141,360 |
| James P Cain | Director | July 15, 2026 A | 13,427 | 0 | 0 | $0 |
| Steve Hash | Director | July 15, 2026 A | 30,997 | 0 | 0 | $0 |
| Richard Hunter Klein | Director | July 15, 2026 A | 21,866 | 0 | 0 | $0 |
| Claire Aldridge | Director | Jan. 15, 2026 A | 4,493 | 0 | 0 | $0 |
| Maria C Freire | Director | Jan. 15, 2026 A | 10,946 | 0 | 0 | $0 |
| Cynthia L Feldmann | Director | Jan. 15, 2025 A | 5,742 | 0 | 0 | $0 |
| Jennifer Friel Goldstein | Director | Jan. 13, 2023 A | 3,784 | 0 | 0 | $0 |
| James H Richardson | Director | March 15, 2021 G | 44,000 | 0 | 0 | $0 |
| John L Atkins III | Director | Jan. 15, 2021 A | 21,554 | 0 | 0 | $0 |
| Martin A Simonetti | Director | Dec. 31, 2012 A | 9,779 | 0 | 0 | $0 |
| Alan G Walton | Director | Dec. 30, 2011 A | 8,708 | 0 | 0 | $0 |
| Anthony Solomon | Director | Jan. 2, 2004 A | 16,863 | 0 | 0 | $0 |
| Richard B Jennings | · | Jan. 15, 2016 A | 30,279 | 0 | 0 | $0 |
| Richmond A Wolf | · | Jan. 1, 2007 A | 6,100 | 0 | 0 | $0 |
| Jerry Sudarsky | · | Aug. 16, 2006 G | 91,760 | 0 | 0 | $0 |
| Nancy Kelley | · | Jan. 31, 2005 A | 10,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 95 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| RSPR · Invesco Exchange-Traded Fund Trust | 3.36% | 57,767 | Oct. 2, 2026 | Daily |
| SRHR · Elevation Series Trust | 3.31% | 35,000 NS | July 31, 2026 | N-PORT |
| KBWY · Invesco Exchange-Traded Fund Trust … | 2.96% | 183,429 | Oct. 2, 2026 | Daily |
| CVAR · ETF Opportunities Trust | 2.12% | 17,686 NS | July 31, 2026 | N-PORT |
| REZ · iShares Trust | 1.81% | 300,834 SH | Sept. 11, 2026 | Daily |
| SPDV · ETF Series Solutions | 1.57% | 40,277 NS | July 31, 2026 | N-PORT |
| BLDG · Cambria ETF Trust | 1.26% | 16,499 NS | July 31, 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1.00% | 349,794 | Oct. 2, 2026 | Daily |
| EPSV · Harbor ETF Trust | 0.92% | 1,087 NS | July 31, 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 0.86% | 783 NS | July 31, 2026 | N-PORT |
| USRT · iShares Trust | 0.74% | 657,282 SH | Sept. 11, 2026 | Daily |
| IYR · iShares Trust | 0.59% | 483,649 SH | Sept. 11, 2026 | Daily |
| DRN · Direxion Shares ETF Trust | 0.58% | 5,034 NS | July 31, 2026 | N-PORT |
| QLC · FlexShares Trust | 0.55% | 107,520 NS | July 31, 2026 | N-PORT |
| FREL · FIDELITY COVINGTON TRUST | 0.52% | 150,088 NS | July 31, 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.48% | 19,760 NS | July 31, 2026 | N-PORT |
| REET · iShares Trust | 0.48% | 467,590 SH | Sept. 11, 2026 | Daily |
| VNQ · VANGUARD SPECIALIZED FUNDS | 0.44% | 5,931,207 SH | Aug. 19, 2026 | Daily |
| ERET · iShares Trust | 0.43% | 1,156 SH | Sept. 11, 2026 | Daily |
| VRP · Invesco Exchange-Traded Fund Trust … | 0.34% | 10,420,000 | Oct. 2, 2026 | Daily |
| GSY · Invesco Actively Managed Exchange-T… | 0.32% | 12,500,000 | Oct. 2, 2026 | Daily |
| IQSM · New York Life Investments ETF Trust | 0.32% | 20,428 NS | July 31, 2026 | N-PORT |
| DFGR · Dimensional ETF Trust | 0.30% | 226,231 NS | July 31, 2026 | N-PORT |
| DFAR · Dimensional ETF Trust | 0.29% | 101,475 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.20% | 2,537,937 SH | Aug. 19, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.19% | 3,880,885 | Oct. 2, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.19% | 24,050 NS | July 31, 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.17% | 65,243 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.15% | 24,755 | Oct. 2, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.13% | 631 NS | July 31, 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.12% | 175,000 | Oct. 2, 2026 | Daily |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.12% | 10,352 SH | Oct. 2, 2026 | Daily |
| SMMD · iShares Trust | 0.12% | 91,820 SH | Sept. 11, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.11% | 3,997,668 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.11% | 59,559 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.09% | 14,018 SH | Sept. 11, 2026 | Daily |
| REVS · Columbia ETF Trust I | 0.08% | 5,509 NS | July 31, 2026 | N-PORT |
| IWS · iShares Trust | 0.08% | 257,327 SH | Sept. 11, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.07% | 19,489 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.06% | 702,771 SH | Sept. 11, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.06% | 254,924 SH | Aug. 19, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.06% | 117,489 | Oct. 2, 2026 | Daily |
| DIVB · iShares Trust | 0.05% | 21,146 SH | Sept. 11, 2026 | Daily |
| XOEF · iShares Trust | 0.04% | 196 SH | Sept. 11, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.04% | 49,111 NS | July 31, 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.03% | 36,169 SH | Aug. 19, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 103,611 SH | Aug. 19, 2026 | Daily |
| IVE · iShares Trust | 0.03% | 260,940 SH | Sept. 11, 2026 | Daily |
| IUSV · iShares Trust | 0.03% | 139,555 SH | Sept. 11, 2026 | Daily |
| IWD · iShares Trust | 0.02% | 380,975 SH | Sept. 11, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.02% | 38,785 SH | Aug. 19, 2026 | Daily |
| TILT · FlexShares Trust | 0.02% | 7,584 NS | July 31, 2026 | N-PORT |
| IGRO · iShares Trust | 0.02% | 6,040 SH | Sept. 11, 2026 | Daily |
| TOPC · iShares Trust | 0.01% | 95 SH | Sept. 11, 2026 | Daily |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.01% | 28,864 | Oct. 2, 2026 | Daily |
| XVV · iShares Trust | 0.01% | 1,794 SH | Sept. 11, 2026 | Daily |
| PTLC · Pacer Funds Trust | 0.01% | 7,884 NS | July 31, 2026 | N-PORT |
| IWB · iShares Trust | 0.01% | 118,974 SH | Sept. 11, 2026 | Daily |
| IVV · iShares Trust | 0.01% | 1,970,181 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.01% | 46,670 SH | Sept. 11, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 931 | Oct. 2, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.01% | 592 NS | July 31, 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.01% | 3,779 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.01% | 6,719 SH | Sept. 11, 2026 | Daily |
| VOXP · Advisors Series Trust | 0.01% | 12 NS | July 31, 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.01% | 3,708 | Oct. 2, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 200,795 SH | Sept. 11, 2026 | Daily |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 4,072,531 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 5,532,724 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 202,500 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.01% | 661,035 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 28,447 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 14,481 SH | Aug. 19, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.01% | 1,090 NS | July 31, 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 12,263 NS | July 31, 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 119 | Oct. 2, 2026 | Daily |
| IDEV · iShares Trust | 0.01% | 88,545 SH | Sept. 11, 2026 | Daily |
| ACVF · ETF Opportunities Trust | 0.01% | 230 NS | July 31, 2026 | N-PORT |
| IXUS · iShares Trust | 0.01% | 112,891 SH | Sept. 11, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 984,885 SH | Aug. 19, 2026 | Daily |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCRB · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| VCEB · VANGUARD WORLD FUND | · | · | July 30, 2026 | Daily |
| ISCB · iShares Trust | · | 6,692 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 32,931 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 72,980 SH | Sept. 11, 2026 | Daily |
ARE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
14 analysts · 2026-10-04Mean target $52.57 +11.0%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ARE | $8.35B | -5.8 | -2.9% | -47.2% | -8.6% | · |
| DOC | $11.18B | 160.8 | 4.5% | 2.5% | 0.90% | · |
| OHI | $13.10B | 22.9 | 13.2% | 49.6% | 12.2% | · |
| AHR | $8.75B | 112.0 | 9.2% | 3.1% | 2.5% | · |
| JAN | · | · | · | · | · | · |
| CTRE | $8.05B | 23.0 | 60.8% | 67.3% | 9.2% | · |
| HR | $5.96B | -23.9 | -6.9% | -20.8% | -5.0% | · |
| SBRA | $4.77B | 29.6 | 10.2% | 20.1% | 5.6% | · |
| NHI | $3.69B | 25.3 | 12.1% | 37.9% | 9.8% | · |
| LTC | $1.67B | 13.6 | 25.3% | 44.9% | 11.6% | · |
| MPT | $2.99B | -10.9 | -2.4% | -28.5% | -5.9% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.